| Unique ID issued by UMIN | UMIN000057635 |
|---|---|
| Receipt number | R000065852 |
| Scientific Title | Extracorporeal shock wave therapy and platelet-rich plasma for bone marrow lesions in knee osteoarthritis: non-randomized controlled trial |
| Date of disclosure of the study information | 2025/04/17 |
| Last modified on | 2025/12/15 15:10:57 |
Extracorporeal shock wave therapy and platelet-rich plasma for bone marrow lesions in knee osteoarthritis
Extracorporeal shock wave therapy and platelet-rich plasma for bone marrow lesions in knee osteoarthritis
Extracorporeal shock wave therapy and platelet-rich plasma for bone marrow lesions in knee osteoarthritis: non-randomized controlled trial
ESWT-PRP trial for KOA-BML
| Japan |
knee osteoarthritis
| Orthopedics | Rehabilitation medicine |
Others
NO
To clarify the effects of combined extracorporeal shock wave and PRP therapy for bone marrow lesions associated with knee osteoarthritis on clinical symptoms, knee joint function and motor function.
Efficacy
Knee flexion range of motion, knee extension range of motion, knee extension muscle strength, hip abduction muscle strength, timed up & go test. time: before intervention, 1 month, 3 months, 5 months
Patient-reported outcome measures: Visual analogue scale, Knee injury and osteoarthritis outcome score, Hospital Anxiety and Ultrasonographic assessment: Distance in suprapatellar sac,Medial meniscal extrusion, Muscle brightness of medial vastus medialis.
Interventional
Parallel
Non-randomized
Open -no one is blinded
Active
3
Treatment
| Device,equipment | Maneuver |
Extracorporeal shock wave (2000 shots, 3 times a week), injection of multi-platelet plasma (once), physical therapy (once a week for 5 months)
Extracorporeal shock wave (2000 shots, 3 times a week), physical therapy (once a week for 5 months)
physical therapy (once a week for 5 months)
| 40 | years-old | <= |
| 80 | years-old | >= |
Male and Female
Patients diagnosed with osteoarthritis of the knee, with a Visual Analogue Scale evaluation of 30 mm or more at the medial knee joint and bone marrow lesions at the medial tibiofemoral joint on MRI.
Grade IV in the Kellgren-Lawrence classification, prior ESWT or PRP therapy, history of knee trauma or neurological disease, bilateral symptomatic knee osteoarthritis, bone marrow lesions with osteonecrosis on MRI findings, systemic diseases such as rheumatoid arthritis, autoimmune diseases, tumors, and contraindications to ESWT systemic diseases such as rheumatoid arthritis, autoimmune diseases, and tumors, as well as those with contraindications to extracorporeal shock wave therapy.
39
| 1st name | Shintarou |
| Middle name | |
| Last name | Kudo |
Morinomiya University of Medical Sciences
Inclusive Medical Sciences Research Institute
559-8611
1-26-16 Nankoukita, Suminoe-ward, Osaka-city, Osaka
0666166911
kudo@morinomiya-u.ac.jp
| 1st name | shun |
| Middle name | |
| Last name | okada |
Morinomiya University of Medical Sciences
research support center
559-8611
1-26-16 Nankoukita, Suminoe-ward, Osaka-city, Osaka
0666166911
kenkyu@morinomiya-u.ac.jp
Morinomiya University of Medical Sciences
Morinomiya University of Medical Sciences
Other
Morinomiya University of Medical Sciences
1-26-16 Nankoukita, Suminoe-ward, Osaka-city, Osaka
0666166911
kenkyu@morinomiya-u.ac.jp
NO
| 2025 | Year | 04 | Month | 17 | Day |
Unpublished
Open public recruiting
| 2025 | Year | 04 | Month | 17 | Day |
| 2024 | Year | 12 | Month | 26 | Day |
| 2025 | Year | 04 | Month | 17 | Day |
| 2028 | Year | 03 | Month | 31 | Day |
| 2025 | Year | 04 | Month | 17 | Day |
| 2025 | Year | 12 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065852